[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Journal Information::
Indexing Sources::
Guide for Authors::
Online Submission::
Articles archive::
For Reviewers::
Contact us::
Basic and Clinical Biochemistry and Nutrition
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
:: Volume 25, Issue 5 (Bimonthly 2021) ::
Feyz 2021, 25(5): 1255-1264 Back to browse issues page
Evaluation of IL-17A rs2275 913 G>A and IL- 17F rs 763780 T>C genes polymorphism in women with breast cancer
Narges Heshemi , Golnaz Asaadi@yahoo.com , Neda Jabara , Kumarss Amini
Azad islamic university of zanjan , golnaz_asaadi@yahoo.com
Abstract:   (1031 Views)
Background: Breast cancer is the most common cancer among women around the world, in which mostly is seen in women over 50 years old age. IL-17 which has the main role in responding to inflammation plays role in the early stages of tumorigenic and primary tumor formation. Epidemiological studies have shown that IL-17 is associated with the risk of cancer. This study aimed to investigatory the relationship between single-nucleotide polymorphisms (SNPs) in the IL-17-A rs2275913 G>A and IL-17 F rs763780 T>C genes in women with breast cancer this study.
Materials and Methods: In this research 50 patients and 50 healthy samples were studied as a control group. After genomic DNA extraction, genotype determination of rs2275913 and     rs763780 polymorphisms was performed by Tetra- ARMS-PCR method and finally the results statistically were analyzed.
Results: In the current research GG, AG and AA genotype frequencies of IL-17A gene in patient and normal samples were [12(24%), 23(46%),15(30%)]  and [21(42%), 27(54%), 2(4%)] respectively, (GA vs GG/AA, OR= 1.49, 95% CI: 0.61-3.67, AA vs GG/GA, OR= 13.12, 95% CI: 2.55-67.46). Also the frequency of an allele in patient and normal population was detected 53% and 31% respectively. IL-17A-197A allele in comparison with G significantly increased risk of breast cancer (OR= 2.510, 95% CI: 1.408-4.473). No significant difference was observed between IL-17 F 7488 T>C gene’s polymorphism and breast cancer’s incidence (OR= 1/000, 95% CI: 0.24-4.24).
Conclusion: The results indicated that IL-17A rs2275913G>A polymorphism was associated with breast cancer in women, which could be effective in the treatment and clinical management of this disease. In contrast, IL-17F rs763780T>C polymorphism did not showed significant association with the susceptibility of breast cancer.
Keywords: Breast cancer, polymorphism, IL-17A, IL-17F
Full-Text [PDF 952 kb]   (637 Downloads)    
Type of Study: Research | Subject: medicine, paraclinic
Received: 2021/05/20 | Revised: 2021/12/26 | Accepted: 2021/10/19 | Published: 2021/11/28
Send email to the article author

Add your comments about this article
Your username or Email:


XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

heshemi N, asaadi@yahoo.com G, jabara N, Amini K. Evaluation of IL-17A rs2275 913 G>A and IL- 17F rs 763780 T>C genes polymorphism in women with breast cancer. Feyz 2021; 25 (5) :1255-1264
URL: http://feyz.kaums.ac.ir/article-1-4401-en.html

Creative Commons License
This open access journal is licensed under a Creative Commons Attribution-NonCommercial ۴.۰ International License. CC BY-NC ۴. Design and publishing by Kashan University of Medical Sciences.
Copyright ۲۰۲۳© Feyz Medical Sciences Journal. All rights reserved.
Volume 25, Issue 5 (Bimonthly 2021) Back to browse issues page
مجله علوم پزشکی فیض Feyz Medical Sciences Journal
Persian site map - English site map - Created in 0.05 seconds with 46 queries by YEKTAWEB 4645